BG104722A - Method for preparing sulfanyl-type endothelin receptor antagonists - Google Patents

Method for preparing sulfanyl-type endothelin receptor antagonists

Info

Publication number
BG104722A
BG104722A BG104722A BG10472200A BG104722A BG 104722 A BG104722 A BG 104722A BG 104722 A BG104722 A BG 104722A BG 10472200 A BG10472200 A BG 10472200A BG 104722 A BG104722 A BG 104722A
Authority
BG
Bulgaria
Prior art keywords
sulfanyl
preparing
receptor antagonists
endothelin receptor
aryl
Prior art date
Application number
BG104722A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wilhelm Amberg
Rolf Jansen
Dagmar Klinge
Original Assignee
Abbott Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co. Kg filed Critical Abbott Gmbh & Co. Kg
Publication of BG104722A publication Critical patent/BG104722A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG104722A 1998-03-06 2000-08-28 Method for preparing sulfanyl-type endothelin receptor antagonists BG104722A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19809635A DE19809635A1 (de) 1998-03-06 1998-03-06 Verfahren zur Darstellung von Endothelinrezeptorantagonisten vom Sulfanyltyp
PCT/EP1999/001209 WO1999044988A2 (de) 1998-03-06 1999-02-25 Verfahren zur darstellung von endothelinrezeptorantagonisten vom sulfanyltyp

Publications (1)

Publication Number Publication Date
BG104722A true BG104722A (en) 2001-05-31

Family

ID=7859948

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104722A BG104722A (en) 1998-03-06 2000-08-28 Method for preparing sulfanyl-type endothelin receptor antagonists

Country Status (22)

Country Link
US (1) US6235903B1 (no)
EP (1) EP1060168A2 (no)
JP (1) JP2002505319A (no)
KR (1) KR20010041631A (no)
CN (1) CN1292783A (no)
AR (1) AR018145A1 (no)
AU (1) AU3408799A (no)
BG (1) BG104722A (no)
BR (1) BR9908585A (no)
CA (1) CA2322226A1 (no)
CO (1) CO4790169A1 (no)
DE (1) DE19809635A1 (no)
HR (1) HRP20000649A2 (no)
HU (1) HUP0100857A3 (no)
ID (1) ID26348A (no)
IL (1) IL137538A0 (no)
NO (1) NO20004422L (no)
PL (1) PL343426A1 (no)
SK (1) SK12012000A3 (no)
TR (1) TR200002577T2 (no)
WO (1) WO1999044988A2 (no)
ZA (1) ZA991779B (no)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU620573B2 (en) * 1987-11-27 1992-02-20 Societe Nationale Elf Aquitaine Process for phenol alkylthiolation and its application to the synthesis of 4-acyl-2-alkylthiophenols
DE4313412A1 (de) 1993-04-23 1994-10-27 Basf Ag 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung
DE4411225A1 (de) 1994-03-31 1995-10-05 Basf Ag Verwendung von Carbonsäurederivaten als Arzneimittel
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
US5719292A (en) * 1997-03-27 1998-02-17 Eastman Kodak Company Process for preparing a thioether compound

Also Published As

Publication number Publication date
NO20004422D0 (no) 2000-09-05
DE19809635A1 (de) 1999-09-09
NO20004422L (no) 2000-09-05
KR20010041631A (ko) 2001-05-25
AU3408799A (en) 1999-09-20
BR9908585A (pt) 2000-11-21
PL343426A1 (en) 2001-08-13
WO1999044988A2 (de) 1999-09-10
US6235903B1 (en) 2001-05-22
EP1060168A2 (de) 2000-12-20
HUP0100857A2 (hu) 2001-08-28
ID26348A (id) 2000-12-14
CO4790169A1 (es) 1999-05-31
WO1999044988A3 (de) 1999-11-11
AR018145A1 (es) 2001-10-31
JP2002505319A (ja) 2002-02-19
HRP20000649A2 (en) 2001-06-30
TR200002577T2 (tr) 2000-11-21
CN1292783A (zh) 2001-04-25
HUP0100857A3 (en) 2001-12-28
ZA991779B (en) 2000-10-11
CA2322226A1 (en) 1999-09-10
SK12012000A3 (sk) 2001-01-18
IL137538A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
ES2070660A1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
EP1260510A4 (en) FLUORESCENT PROBES FOR THE QUANTIFICATION OF ZINC
EP0320118A3 (en) Peptides with collagenase inhibiting activity
MD960282A (en) Herbicidal heterocyclic-substituted pyridines
AU5301199A (en) Oxindole derivatives as growth hormone releasers
EP1454890A3 (en) Anti-tumor Acylfulvenes
EP0900789A3 (en) Substituted quinolone derivatives and pharmaceuticals containing the same
GR79370B (no)
TR200002838T2 (tr) Bir sefalosporin türevinin arıtımı için proses
BG104722A (en) Method for preparing sulfanyl-type endothelin receptor antagonists
GB9815910D0 (en) Synthetic method
EP1028118A4 (en) METHOD FOR PRODUCING 3-CEPHEM COMPOUNDS
DK0953563T3 (da) Fremgangsmåde til fremstilling af depsipeptidderivater samt hidtil ukendte intermediater derfor
EP1186616A4 (en) ANTIFUCOIDAN ANTIBODY
IE820125L (en) Composition
PL347503A1 (en) Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols
AU2926599A (en) Method for producing trifluoro-3(r)-hydroxybutyric acid derivatives
EP1142892A4 (en) METHOD FOR PRODUCING NEW NAPHTYRIDINE DERIVATIVES
BR9811481B1 (pt) processo para a preparação de derivados de 1,3-diazo-spiro (4,4) non-1-en-4-ona e intermediários de 1-ciano-1-acil amino ciclopentano.
PL352465A1 (en) Novel method of obtaining n-(1,1-dimethyl)-4-[[5'-ethoxy-4-cis[2-[4-morpholin]ethoxy]2'-oxospiro[cycloexane-1,3'-[3h]indol]-1'(2'h)yl]-sulphonyl]-3-methoxybenzamide and its salts
AU7491794A (en) A process for preparing 5-chloro-4-hydroxypyrimidines, 2-chloro enamines as intermediates in this process and their use
MY134147A (en) Method for stoping hysteresis
NZ333769A (en) A process for preparing naphthyridones and azabicyclo(3.1.0)hexane intermediates for the compound trovafloxacin and derivatives thereof
TW200712054A (en) Method for producing 2,3-dihydropyridazine compound
DE59704918D1 (de) Verfahren zur Herstellung von substituierten Pyrimidinen